Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors

被引:60
作者
Lee, HW
Lee, SH
Lee, HW
Ryu, YW
Kwon, MH
Kim, YS
机构
[1] Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea
[2] Ajou Univ, Sch Med, Dept Microbiol, Suwon 442749, South Korea
关键词
TRAIL; death receptors; death decoy receptors; homomeric and heteromeric interactions; SPR;
D O I
10.1016/j.bbrc.2005.03.101
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Death receptors (DRs) can induce apoptosis by oligomerization with TRAIL, whereas death decoy receptors (DcRs) cannot, due to their lack of functional intracellular death domains. However, it is not known whether DRs and DcRs can interact with one another to form oligomeric complexes prior to TRAIL binding. To address this issue, the extracellular domains (ECDs) of DR4 (sDR4), DR5 (sDR5), DcR1 (sDcR1), and DcR2 (sDcR2) were expressed in a soluble, monomeric form, and their binding interactions were quantified by surface plasmon resonance. The purified sDRs and sDcRs exhibited native-like secondary structure and bound to TRAIL with binding affinities in the nanomolar range (K-D = similar to 10-62 nM), suggesting that they were properly folded and functional. The soluble receptors interacted homophilically and heterophilically with similar micromolar range affinities (K-D = similar to 1-9 mu M), with the exception that sDR5 did not interact with the sDcRs. Our results suggest that most DRs and DcRs can laterally interact through their ECDs to form homomeric and/or heteromeric complexes in the absence of TRAIL binding. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1205 / 1212
页数:8
相关论文
共 31 条
[1]   Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy [J].
Almasan, A ;
Ashkenazi, A .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (3-4) :337-348
[2]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[3]   Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity [J].
Cha, SS ;
Sung, BJ ;
Kim, YA ;
Song, YL ;
Kim, HJ ;
Kim, S ;
Lee, MS ;
Oh, BH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) :31171-31177
[4]   2.8 Å resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity [J].
Cha, SS ;
Kim, MS ;
Choi, YH ;
Sung, BJ ;
Shin, NK ;
Shin, HC ;
Sung, YC ;
Oh, BH .
IMMUNITY, 1999, 11 (02) :253-261
[5]   A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling [J].
Chan, FKM ;
Chun, HJ ;
Zheng, LX ;
Siegel, RM ;
Bui, KL ;
Lenardo, MJ .
SCIENCE, 2000, 288 (5475) :2351-2354
[6]   The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain [J].
Degli-Esposti, MA ;
Dougall, WC ;
Smolak, PJ ;
Waugh, JY ;
Smith, CA ;
Goodwin, RG .
IMMUNITY, 1997, 7 (06) :813-820
[7]   Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL [J].
Emery, JG ;
McDonnell, P ;
Burke, MB ;
Deen, KC ;
Lyn, S ;
Silverman, C ;
Dul, E ;
Appelbaum, ER ;
Eichman, C ;
DiPrinzio, R ;
Dodds, RA ;
James, IE ;
Rosenberg, M ;
Lee, JC ;
Young, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14363-14367
[8]  
Griffith TS, 1999, J IMMUNOL, V162, P2597
[9]   A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL [J].
Hymowitz, SG ;
O'Connell, MP ;
Ultsch, MH ;
Hurst, A ;
Totpal, K ;
Ashkenazi, A ;
de Vos, AM ;
Kelley, RF .
BIOCHEMISTRY, 2000, 39 (04) :633-640
[10]   Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5 [J].
Hymowitz, SG ;
Christinger, HW ;
Fuh, G ;
Ultsch, M ;
O'Connell, M ;
Kelley, RF ;
Ashkenazi, A ;
de Vos, AM .
MOLECULAR CELL, 1999, 4 (04) :563-571